Rare lephants
Screener

SELLAS Life Sciences Group, Inc.

SLS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4/A Mar 16, 2018 FORM 4/A SUBMISSION
4 Mar 16, 2018 FORM 4 SUBMISSION
3 Mar 16, 2018 FORM 3 SUBMISSION
4 Mar 15, 2018 FORM 4 SUBMISSION
4 Mar 15, 2018 FORM 4 SUBMISSION
4 Mar 15, 2018 FORM 4 SUBMISSION
4 Mar 15, 2018 FORM 4 SUBMISSION
4 Mar 15, 2018 FORM 4 SUBMISSION
4 Mar 15, 2018 FORM 4 SUBMISSION
4 Mar 15, 2018 FORM 4 SUBMISSION
4 Mar 15, 2018 FORM 4 SUBMISSION
4 Mar 15, 2018 FORM 4 SUBMISSION
SC 13D/A Mar 13, 2018 SC 13D AMENDMENT NO. 1
8-K Mar 12, 2018 FORM 8-K
8-K Feb 27, 2018 FORM 8-K
8-K Feb 20, 2018 FORM 8-K
8-K Feb 12, 2018 8-K
SC 13G/A Feb 9, 2018 SC 13G/A
8-K Jan 18, 2018 8-K
8-K/A Jan 11, 2018 FORM 8-K/A
SC 13D Jan 8, 2018 SC 13D
SC 13D Jan 8, 2018 SC 13D
SC 13G/A Jan 8, 2018 SABBY 13G-A SLS 1.08.18
8-K Jan 5, 2018 FORM 8-K
4 Dec 29, 2017 FORM 4 SUBMISSION
← Newer Page 18 of 51 · 1272 filings Older →